Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester B Whitley

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Annals of Internal Medicine|December 21, 2006
Agalsidase-beta therapy for advanced Fabry disease: a randomized trialMaryam Banikazemi, Jan Bultas, Stephen Waldek, et al.
Molecular Genetics and Metabolism|July 6, 2023
Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screeningNishitha R Pillai, Noelle Andrea V Fabie, Tory V Kaye, et al.
Molecular Genetics and Metabolism|February 18, 2020
The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VIIRaymond Y Wang, José Francisco da Silva Franco, Jaime López-Valdez, et al.
Clinical Genetics|June 14, 2019
Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I RegistryLorne A Clarke, Roberto Giugliani, Nathalie Guffon, et al.
Molecular Genetics and Metabolism|August 27, 2020
Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]Raymond Y Wang, José Francisco da Silva Franco, Jaime López-Valdez, et al.
Molecular Genetics and Metabolism Reports|April 15, 2021
Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosisMichael J Przybilla, Christine Stewart, Timothy W Carlson, et al.
Pediatrics|July 3, 2003
Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometryDietrich Matern, Miao He, Susan A Berry, et al.
Lancet (London, England)|August 19, 2007
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled studyHarvey L Levy, Andrzej Milanowski, Anupam Chakrapani, et al.
Molecular Genetics and Metabolism|January 13, 2019
Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIBChester B Whitley, Suresh Vijay, Bert Yao, et al.
The Journal of Gene Medicine|April 5, 2007
Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidosesElena L Aronovich, Jason B Bell, Lalitha R Belur, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Annals of Internal Medicine|December 21, 2006
Agalsidase-beta therapy for advanced Fabry disease: a randomized trialMaryam Banikazemi, Jan Bultas, Stephen Waldek, et al.
Molecular Genetics and Metabolism|July 6, 2023
Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screeningNishitha R Pillai, Noelle Andrea V Fabie, Tory V Kaye, et al.
Molecular Genetics and Metabolism|February 18, 2020
The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VIIRaymond Y Wang, José Francisco da Silva Franco, Jaime López-Valdez, et al.
Clinical Genetics|June 14, 2019
Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I RegistryLorne A Clarke, Roberto Giugliani, Nathalie Guffon, et al.
Molecular Genetics and Metabolism|August 27, 2020
Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]Raymond Y Wang, José Francisco da Silva Franco, Jaime López-Valdez, et al.
Molecular Genetics and Metabolism Reports|April 15, 2021
Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosisMichael J Przybilla, Christine Stewart, Timothy W Carlson, et al.
Pediatrics|July 3, 2003
Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometryDietrich Matern, Miao He, Susan A Berry, et al.
Lancet (London, England)|August 19, 2007
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled studyHarvey L Levy, Andrzej Milanowski, Anupam Chakrapani, et al.
Molecular Genetics and Metabolism|January 13, 2019
Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIBChester B Whitley, Suresh Vijay, Bert Yao, et al.
The Journal of Gene Medicine|April 5, 2007
Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidosesElena L Aronovich, Jason B Bell, Lalitha R Belur, et al.
Pageof 12